IVA Inventiva S.A. - American Depository Shares

NASDAQ · Biotechnology
$4.74
Price · Aug 19, 2026

IVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$4.74
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$3 – $8

IVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
IVA
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
IVA
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
IVA
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
IVA
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
IVA
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
IVA
Peer Median

IVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 17 analysts
  • Strong Buy 8 47.1%
  • Buy 8 47.1%
  • Hold 1 5.9%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

13 analysts · 2026-08-18
Median target $13.00 +174.6%
Mean target $14.88 +214.3%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 89 filers · $309.7M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
32 (+10 vs prior Q) 6 (-5 vs prior Q) 35 (+17 vs prior Q) 7 (-3 vs prior Q) +31.9M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Caligan Partners LP $30,856,862 8,163,191 9.96% Shares
SAMSARA BIOCAPITAL, LLC $23,869,963 6,314,805 7.71% Shares
Paradigm Biocapital Advisors LP $15,120,000 4,000,000 4.88% Shares
ANDERA PARTNERS $13,733,424 3,633,181 4.43% Shares
ADAR1 Capital Management, LLC $13,633,160 3,606,656 4.40% Shares
MILLENNIUM MANAGEMENT LLC $13,276,018 3,512,174 4.29% Shares
SymBiosis Capital Partners, LLC $13,064,700 2,354,000 4.22% Shares
Nantahala Capital Management, LLC $10,154,566 2,686,393 3.28% Shares
Trails Edge Capital Partners, LP $10,047,228 2,657,997 3.24% Shares
FRANKLIN RESOURCES INC $9,989,070 2,642,611 3.22% Shares
Squadron Capital Management LLC $9,204,300 2,435,000 2.97% Shares
Woodline Partners LP $8,781,503 2,323,149 2.84% Shares
Aberdeen Group plc $8,723,382 2,307,773 2.82% Shares
BOOTHBAY FUND MANAGEMENT, LLC $7,574,296 2,003,782 2.45% Shares
Patient Square Capital LP $7,435,906 1,967,171 2.40% Shares
NEXTBio Capital Management LP $6,758,580 1,787,984 2.18% Shares
AMERIPRISE FINANCIAL INC $6,415,219 1,697,148 2.07% Shares
Point72 Asset Management, L.P. $6,361,785 1,683,012 2.05% Shares
CITADEL ADVISORS LLC $5,821,200 1,540,000 1.88% Shares
Integral Health Asset Management, LLC $5,745,600 1,520,000 1.85% Shares
Yu Fan $5,670,000 1,500,000 1.83% Shares
NEA Management Company, LLC $5,528,575 1,462,586 1.78% Shares
STEMPOINT CAPITAL LP $5,391,490 1,426,320 1.74% Shares
Propel Bio Management, LLC $4,842,981 1,281,212 1.56% Shares
KINGDON CAPITAL MANAGEMENT, L.L.C. $4,800,600 1,270,000 1.55% Shares
JPMORGAN CHASE & CO $4,647,305 1,309,100 1.50% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $4,233,600 1,120,000 1.37% Shares
Ikarian Capital, LLC $4,152,521 1,129,101 1.34% Shares
Polar Capital Holdings Plc $4,060,529 1,074,214 1.31% Shares
Alyeska Investment Group, L.P. $3,436,020 909,000 1.11% Shares
HighVista Strategies LLC $3,142,851 831,442 1.01% Shares
Deep Track Capital, LP $3,024,000 800,000 0.98% Shares
TWO SIGMA INVESTMENTS, LP $2,752,260 728,111 0.89% Shares
DIADEMA PARTNERS LP $2,725,718 740,786 0.88% Shares
BVF INC/IL $2,593,231 686,040 0.84% Shares
FMR LLC $2,590,812 685,400 0.84% Shares
Ally Bridge Group (NY) LLC $2,399,544 634,800 0.77% Shares
Qube Research & Technologies Ltd $1,502,769 397,558 0.49% Shares
JANE STREET GROUP, LLC $1,386,523 366,805 0.45% Shares
J. Goldman & Co LP $1,275,750 337,500 0.41% Shares
Simplify Asset Management Inc. $1,184,966 313,483 0.38% Shares
Artisan Partners Limited Partnership $996,174 263,538 0.32% Shares
Ghisallo Capital Management LLC $945,000 250,000 0.31% Shares
Burkehill Global Management, LP $850,500 225,000 0.27% Shares
SEVEN GRAND MANAGERS, LLC $850,500 225,000 0.27% Shares
GOLDMAN SACHS GROUP INC $848,606 224,499 0.27% Shares
XTX Topco Ltd $809,986 214,282 0.26% Shares
Quadrature Capital Ltd $783,148 207,182 0.25% Shares
Seven Fleet Capital Management LP $756,533 200,141 0.24% Shares
BANK OF AMERICA CORP /DE/ $574,247 151,917 0.19% Shares
Balyasny Asset Management L.P. $545,004 144,181 0.18% Shares
Persistent Asset Partners Ltd $530,028 140,219 0.17% Shares
Walleye Capital LLC $512,749 135,648 0.17% Shares
Hudson Bay Capital Management LP $434,700 115,000 0.14% Shares
Rathbones Group PLC $378,000 100,000 0.12% Shares
COMMONWEALTH EQUITY SERVICES, LLC $317,500 83,996 0.10% Shares
Engineers Gate Manager LP $268,818 71,116 0.09% Shares
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $157,922 36,726 0.05% Shares
Jefferies Financial Group Inc. $151,200 40,000 0.05% Shares
GEODE CAPITAL MANAGEMENT, LLC $129,861 34,355 0.04% Shares
R Squared Ltd $113,090 29,918 0.04% Shares
Quaker Wealth Management, LLC $94,349 24,960 0.03% Shares
NEW YORK STATE COMMON RETIREMENT FUND $92,485 24,467 0.03% Shares
Shay Capital LLC $82,672 21,871 0.03% Shares
China Universal Asset Management Co., Ltd. $81,648 21,600 0.03% Shares
UBS Group AG $76,685 20,287 0.02% Shares
NewEdge Advisors, LLC $75,895 20,078 0.02% Shares
Cerity Partners LLC $75,600 20,000 0.02% Shares
ROYAL BANK OF CANADA $60,000 15,741 0.02% Shares
Ground Swell Capital, LLC $48,395 12,803 0.02% Shares
BLAIR WILLIAM & CO/IL $37,800 10,000 0.01% Shares
Frec Markets, Inc. $37,800 10,000 0.01% Shares
MARSHALL WACE, LLP $29,277 7,745 0.01% Shares
CITIGROUP INC $24,993 6,612 0.01% Shares
GAMMA Investing LLC $18,976 5,020 0.01% Shares
RHUMBLINE ADVISERS $17,656 4,672 0.01% Shares
Tower Research Capital LLC (TRC) $6,804 1,800 0.00% Shares
BARCLAYS PLC $6,732 1,781 0.00% Shares
Stone House Investment Management, LLC $5,530 1,463 0.00% Shares
SYQUANT CAPITAL SAS $3,452 913,135 0.00% Shares
MORGAN STANLEY $1,690 447 0.00% Shares
OSAIC HOLDINGS, INC. $1,164 308 0.00% Shares
Atlantic Union Bankshares Corp $1,134 300 0.00% Shares
Larson Financial Group LLC $851 225 0.00% Shares
Caitong International Asset Management Co., Ltd $586 155 0.00% Shares
HRT FINANCIAL LP $468 123,953 0.00% Shares
Bell Investment Advisors, Inc $288 76 0.00% Shares
Arax Advisory Partners $193 51 0.00% Shares
Covestor Ltd $2 402 0.00% Shares

Activists & 5%+ owners 4 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 filings April 1, 2026 4.90% Amendment Passive investment SEC
BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N ×3 filings Nov. 19, 2025 4.99% Amendment SEC
Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×2 filings Nov. 19, 2025 7.40% Amendment SEC
BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT ×4 filings Oct. 21, 2024 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 4 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IEUS · iShares Trust 0.03% 10,902 SH Aug. 8, 2026 Daily
ISCF · iShares Trust 0.01% 17,398 SH Aug. 8, 2026 Daily
SCZ · iShares Trust 0.01% 332,648 SH Aug. 8, 2026 Daily
APIE · Trust for Professional Managers 0.00% 8,145 NS May 31, 2026 N-PORT